Loading
JPXHealthcareMedical - Devices
Latest quote
¥2,035
−¥5.00 · -0.25%
Techno Medica Co., Ltd. is a Japanese company that specializes in the entire lifecycle of in-vitro diagnostic analyzers, covering their research, development, manufacturing, distribution, and international trade. Their product portfolio includes automated systems for test tube preparation, urine aliquot, and RFID-based management solutions for both biological specimens and blood transfusions. The company also supplies a diverse range of analytical instruments for measuring blood gases, electrolytes, erythrocyte sedimentation rates, nutrient levels, sugar and acid content, and for performing urine chemistry tests. Furthermore, Techno Medica provides electronic medical charting systems, various pre-analytical devices, essential consumables, and comprehensive after-sales support. Established in 1987, the company's main office is located in Yokohama, Japan.
Latest quote
¥2,035
−¥5.00 · -0.25%
Regular session · JST · Market data may be delayed.
Techno Medica Co., Ltd. is a Japanese company that specializes in the entire lifecycle of in-vitro diagnostic analyzers, covering their research, development, manufacturing, distribution, and international trade. Their product portfolio includes automated systems for test tube preparation, urine aliquot, and RFID-based management solutions for both biological specimens and blood transfusions. The company also supplies a diverse range of analytical instruments for measuring blood gases, electrolytes, erythrocyte sedimentation rates, nutrient levels, sugar and acid content, and for performing urine chemistry tests. Furthermore, Techno Medica provides electronic medical charting systems, various pre-analytical devices, essential consumables, and comprehensive after-sales support. Established in 1987, the company's main office is located in Yokohama, Japan.
Day range
Current ¥2,035
52-week range
Current ¥2,035
Regular session · JST · Market data may be delayed.
Techno Medica Co., Ltd. is a Japanese company that specializes in the entire lifecycle of in-vitro diagnostic analyzers, covering their research, development, manufacturing, distribution, and international trade. Their product portfolio includes automated systems for test tube preparation, urine aliquot, and RFID-based management solutions for both biological specimens and blood transfusions. The company also supplies a diverse range of analytical instruments for measuring blood gases, electrolytes, erythrocyte sedimentation rates, nutrient levels, sugar and acid content, and for performing urine chemistry tests. Furthermore, Techno Medica provides electronic medical charting systems, various pre-analytical devices, essential consumables, and comprehensive after-sales support. Established in 1987, the company's main office is located in Yokohama, Japan.
Day range
Current ¥2,035
52-week range
Current ¥2,035
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.24B JPY | 9.91B JPY | 10.28B JPY | 9.37B JPY | 9.7B JPY |
| Cost of goods sold | 5.99B JPY | 5.03B JPY | 5.18B JPY | 4.78B JPY | 4.92B JPY |
| Gross profit | 5.24B JPY | 4.88B JPY | 5.1B JPY | 4.59B JPY | 4.78B JPY |
| Research and development | — | 690.52M JPY | 516.25M JPY | 369.27M JPY | 405.55M JPY |
| Selling, general, and administrative | 3.57B JPY | 2.89B JPY | 2.75B JPY | 2.57B JPY | 2.52B JPY |
| Operating expenses | 3.57B JPY | 3.58B JPY | 3.26B JPY | 2.94B JPY | 2.92B JPY |
| Interest income | 17.69M JPY | 5.12M JPY | 216K JPY | 162K JPY | 1.18M JPY |
| Depreciation and amortization | 92.37M JPY | 99.66M JPY | 112.98M JPY | 108.06M JPY | 101.46M JPY |
| Operating income | 1.67B JPY | 1.3B JPY | 1.84B JPY | 1.65B JPY | 1.86B JPY |
| Net income | 1.07B JPY | 1B JPY | 1.35B JPY | 1.15B JPY | 1.28B JPY |
Company facts updated Sep 7, 2026.
Recent quarterly results
Recent quarterly results
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Sep 26, 2013 | 300:1 | — | — |
Effective Sep 26, 2013
300:1
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
